Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lars Fjellbirkeland"'
Autor:
Yngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, Åslaug Helland, Bjørn Møller, Sissel Gyrid Freim Wahl, Steinar Solberg
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The main focus on the characteristics of malignant lung tumours has been the size, position within the lobe, and infiltration into neighbouring structures. The aim of this study was to investigate the distribution and characterist
Externí odkaz:
https://doaj.org/article/5875a883bc094aa79f00eb35ae725d73
Autor:
Dan Lærum, Trond-Eirik Strand, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Falk, Michael T. Durheim, Lars Fjellbirkeland
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Whether sex is an independent prognostic factor in lung cancer survival is the subject of ongoing debate. Both large national registries and single hospital studies have shown conflicting findings. In this study, we explore the impact of
Externí odkaz:
https://doaj.org/article/7c8d766c6204494fac73795780a3ffea
Autor:
Dan Laerum, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Falk, Trond-Eirik Strand, Lars Fjellbirkeland
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100477- (2021)
Background: Small-cell lung cancer (SCLC) is an aggressive, rapidly progressive malignancy. Thus, expedient diagnosis and treatment initiation is important. This study identifies and quantifies factors associated with delayed diagnosis and treatment
Externí odkaz:
https://doaj.org/article/6791caff9ae246a7a001c301504e0423
Autor:
Dan Laerum, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Falk, Trond-Erik Strand, Lars Fjellbirkeland
Publikováno v:
Cancer Treatment and Research Communications, Vol 23, Iss , Pp 100168- (2020)
Objectives: Patients with non-small cell lung cancer (NSCLC) may experience progression and stage shift due to delays in a complex and time-consuming diagnostic work-up. We have analyzed the impact of both a local and national intervention on total t
Externí odkaz:
https://doaj.org/article/99ecb231f07d4b9f9b88e2fccb12a075
Autor:
Steinar Solberg, Yngvar Nilssen, Odd Terje Brustugun, Per Magnus Haram, Åslaug Helland, Bjørn Møller, Trond-Eirik Strand, Sissel Gyrid Freim Wahl, Lars Fjellbirkeland
Publikováno v:
Lung Cancer
Objectives: A prerequisite for utilizing the tumour, lymph-nodes, and metastases (TNM) for the staging of lung cancer patients is a high quality of the reported data on which the staging is based. The aim of this study was to investigate the concorda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f229e2a16c537a3cf30db4a974ff9ac
https://hdl.handle.net/11250/3052061
https://hdl.handle.net/11250/3052061
Autor:
Odd Terje, Brustugun, Sveinung, Sørhaug, Bjørn Henning, Grønberg, Marianne, Aanerud, Mohammed Modar Zayd, Al-Zubayidy, Lars, Fjellbirkeland, Åslaug, Helland, Janna, Berg, Brynjar, Andreassen, Erna Elise, Paulsen, Per Magnus, Haram, Haseem, Ashraf, Sissel Gyrid Freim, Wahl
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 140(5)
Autor:
Trond Eirik Strand, Dan Laerum, Lars Fjellbirkeland, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Sørum Falk
Publikováno v:
Cancer Treatment and Research Communications, Vol 23, Iss, Pp 100168-(2020)
Cancer Treatment and Research Communications
Cancer Treatment and Research Communications
Objectives Patients with non-small cell lung cancer (NSCLC) may experience progression and stage shift due to delays in a complex and time-consuming diagnostic work-up. We have analyzed the impact of both a local and national intervention on total ti
Autor:
Sameer Bhargava, Inger Kristin Larsen, Rune Kvåle, Linn M. Åsli, Håvard Thøgersen, Trude Eid Robsahm, Lars Fjellbirkeland, Bjørn Møller, Stein Aaserud, Ronnie Babigumira
Publikováno v:
Acta Oncologica
Background: There are concerns about timely access to appropriate cancer treatment for the growing immigrant population in Norway. This study aims to compare waiting times between cancer diagnosis and start of cancer treatment, as well as treatment p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::248ea9ecd68669f0c7a9ba17c37874db
https://hdl.handle.net/11250/3066829
https://hdl.handle.net/11250/3066829
Autor:
Per Magnus Haram, Mohammed Modar Zayd Al-Zubayidy, Marianne Aanerud, Lars Fjellbirkeland, Erna-Elise Paulsen, Odd Terje Brustugun, Sissel Gyrid Freim Wahl, Bjørn Henning Grønberg, Åslaug Helland, Haseem Ashraf, Janna Berg, Sveinung Sørhaug, Brynjar Andreassen
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Lars Fjellbirkeland, Bjørn Møller, Steinar Solberg, Bjørn Henning Grønberg, Trond Eirik Strand, Tom Kristian Grimsrud, Yngvar Nilssen, Marianne Aanerud, Nina Helbekkmo, Odd Terje Brustugun, Åslaug Helland
Publikováno v:
Lung Cancer. 122:138-145
Introduction There have been significant changes in both diagnostic procedures and therapy for lung cancer since the beginning of the millennium. National incidence and survival data from 2000 through 2016 are studied. Methods National data on cancer